Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

UNCOVERED: How is boston scientific s stock performance compared to other medical device stocks - Caught on Camera

With a market cap of $155.7 billion, Boston Scientific Corporation (BSX) is a global medical device company operating through three segments: Cardiovascular, Rhythm and Neuro, and MedSurg. It offers technologies such as drug-eluting stents, implantable cardiac devices, and systems for gastrointestinal, urological, and neurological treatments.

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Boston Scientific fits this criterion perfectly. Boston Scientific has pursued both organic innovation and strategic acquisitions to build a comprehensive portfolio addressing complex diseases, including coronary artery disease, chronic pain, and cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.